Evidence map›Paper›PMID 28711855›Full record

ReviewCurrent opinion in biotechnology2017

Exploiting and engineering hemoproteins for abiological carbene and nitrene transfer reactions.

Oliver F Brandenberg, Rudi Fasan, Frances H Arnold

Abstract readReview
In one paragraph

Review in Current opinion in biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Borylcyclopropanes: Synthetic Strategies and Applications.Angewandte Chemie (International ed. in English) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Harnessing Photoenzymatic Systems for Intermolecular C-H Fluorination.Angewandte Chemie (International ed. in English) · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. bioRxiv : the preprint server for biology · 2025
    Article
  15. Recent Developments in Catalytic Asymmetric Aziridination.Topics in current chemistry (Cham) · 2025
    Review
  16. Photobiocatalytic Enantioselective Benzylic C(spJournal of the American Chemical Society · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Catalyzing PET-RAFT Polymerizations Using Inherently Photoactive Zinc Myoglobin.Angewandte Chemie (International ed. in English) · 2025
    Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Oliver F BrandenbergDivision of Chemistry and Chemical Engineering, California Institute of Technology, 1200 East California Blvd, Pasadena, CA 91125, USA.
Rudi FasanDepartment of Chemistry, University of Rochester, Hutchison Hall, 120 Trustee Rd, Rochester, NY 14627, USA. Electronic address: rfasan@ur.rochester.edu.
Frances H ArnoldDivision of Chemistry and Chemical Engineering, California Institute of Technology, 1200 East California Blvd, Pasadena, CA 91125, USA. Electronic address: frances@cheme.caltech.edu.

Funding

Selective P450 Oxidation Catalysts for Synthesis of Bioactive MoleculesR01GM098628 · NIGMS · UNIVERSITY OF TEXAS DALLAS · PI FASAN, RUDI · 2012 to 2024
$4.7M
NIGMS NIH HHS R01 GM098628
6 · The paper itself

Abstract

The surge in reports of heme-dependent proteins as catalysts for abiotic, synthetically valuable carbene and nitrene transfer reactions dramatically illustrates the evolvability of the protein world and our nascent ability to exploit that for new enzyme chemistry. We highlight the latest additions to the hemoprotein-catalyzed reaction repertoire (including carbene Si-H and C-H insertions, Doyle-Kirmse reactions, aldehyde olefinations, azide-to-aldehyde conversions, and intermolecular nitrene C-H insertion) and show how different hemoprotein scaffolds offer varied reactivity and selectivity. Preparative-scale syntheses of pharmaceutically relevant compounds accomplished with these new catalysts are beginning to demonstrate their biotechnological relevance. Insights into the determinants of enzyme lifetime and product yield are providing generalizable cues for engineering heme-dependent proteins to further broaden the scope and utility of these non-natural activities.

Indexed as

BiocatalysisCyclopropanesHemeproteinsIminesMethaneProtein EngineeringcarbenecyclopropaneCyclopropanesHemeproteinsIminesMethanephenylnitrene

Identifiers

PMID28711855
PMCPMC5617781

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.